HANGZHOU TIGERMED CONSULTING CO., LTD · 泰格医药
Last · Shenzhen¥53.17+0.10 (+0.19%)close · yahoo · 7h ago
Vol 9.52M ≈ 495.50M
MA10MA20MA50
Market cap¥45.8B737.9M sh
P/E · TTM483fwd 43.2 · eps 0.11
Beta0.43vs S&P 500
Div yield0.23%annual · TTM
52w range
¥35.57¥67.85
Volume2.4Msession
Issuer
Legal nameHANGZHOU TIGERMED CONSULTING CO., LTD · 泰格医药
HQChina (CN)
ListingCN 300347
ISINCNE100001KV8
SectorHealthcare
IndustryBiotechnology & Medical Research
CurrencyCNY
Entity registrylei:836800HLUNBM1GBF1N91
Org ID9900022262
Websitewww.tigermedgrp.com
Employees11,130
AddressHangzhou Tigermed Consulting Co., Ltd. 20/F Block 8, Room 2001-2010 310051, Hangzhou +86 571 2888 7227
| Revenue | ¥7.3B |
|---|---|
| Operating income | ¥-37.9M |
| Net income | ¥-413.2M |
| Operating margin | -0.5% |
| Net margin | -5.7% |
| Return on equity | -2.0% |
| Period | TTM 2026-06-30 |
Loading chart…
Earnings transcripts
Documents
FormReporting forFiledFlags
Showing 5 of 164 filings